Masayon, Amara Joy G.
HRN: 29-18-17 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/17/2026
AMPICILLIN 250MG (VIAL)
06/17/2026
06/23/2026
IV
45mg
Q12
Prematurity
Pending Pharmacy Acceptance
Indication: Empiric Type of Infection: Unspecified Sepsis Compliance to guidelines: